Back to search
FDAFDA · Food and drugs·Recall number D-0128-2019

Catapres .2 (clonidine hydrochloride, USP) 0.2mg, 100-count bottles, Rx only, Dist. by: Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT 06877 USA. Made in Germany. NDC 0597-0007-01

Published November 7, 2018 · Recall initiated: October 22, 2018

Summary

FDA records drug Class II recall D-0128-2019, published November 7, 2018 and initiated October 22, 2018. Recalling firm: Boehringer Ingelheim Pharmaceuticals, Inc.; Status: Terminated; Reported quantity: 1,380 100-count bottles; Lot: Lot: 757739, EXP 9/2020. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Dissolution Specifications: OOS resultsduring routine stability testing

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Boehringer Ingelheim Pharmaceuticals, Inc.
Distributor
Distributed nationwide in the USA and Puerto Rico
Lot
Lot: 757739, EXP 9/2020
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Catapres .2 (clonidine hydrochloride, USP) 0.2mg, 100-count bottles, Rx only, Dist. by: Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT 06877 USA. Made in Germany. NDC 0597-0007-01 recalled?

Yes. FDA published recall D-0128-2019 on November 7, 2018. Reported hazard: Failed Dissolution Specifications: OOS resultsduring routine stability testing

What should I do if I have this product?

Voluntary: Firm initiated · Letter